PEA15_HUMAN - dbPTM
PEA15_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID PEA15_HUMAN
UniProt AC Q15121
Protein Name Astrocytic phosphoprotein PEA-15
Gene Name PEA15
Organism Homo sapiens (Human).
Sequence Length 130
Subcellular Localization Cytoplasm. Associated with microtubules.
Protein Description Blocks Ras-mediated inhibition of integrin activation and modulates the ERK MAP kinase cascade. Inhibits RPS6KA3 activities by retaining it in the cytoplasm (By similarity). Inhibits both TNFRSF6- and TNFRSF1A-mediated CASP8 activity and apoptosis. Regulates glucose transport by controlling both the content of SLC2A1 glucose transporters on the plasma membrane and the insulin-dependent trafficking of SLC2A4 from the cell interior to the surface..
Protein Sequence MAEYGTLLQDLTNNITLEDLEQLKSACKEDIPSEKSEEITTGSAWFSFLESHNKLDKDNLSYIEHIFEISRRPDLLTMVVDYRTRVLKISEEDELDTKLTRIPSAKKYKDIIRQPSEEEIIKLAPPPKKA
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
4Phosphorylation----MAEYGTLLQDL
----CCCHHHHHHHH
13.0818491316
6Phosphorylation--MAEYGTLLQDLTN
--CCCHHHHHHHHHC
24.3217287340
12PhosphorylationGTLLQDLTNNITLED
HHHHHHHHCCCCHHH
34.2125867546
24UbiquitinationLEDLEQLKSACKEDI
HHHHHHHHHHHHHCC
35.38-
25PhosphorylationEDLEQLKSACKEDIP
HHHHHHHHHHHHCCC
47.7117287340
27S-nitrosylationLEQLKSACKEDIPSE
HHHHHHHHHHCCCCC
6.822212679
28UbiquitinationEQLKSACKEDIPSEK
HHHHHHHHHCCCCCC
59.13-
35AcetylationKEDIPSEKSEEITTG
HHCCCCCCCCCCCCC
68.4623236377
43PhosphorylationSEEITTGSAWFSFLE
CCCCCCCHHHHHHHH
21.8926657352
54UbiquitinationSFLESHNKLDKDNLS
HHHHHCCCCCCCCCH
53.27-
56AcetylationLESHNKLDKDNLSYI
HHHCCCCCCCCCHHH
58.85-
61PhosphorylationKLDKDNLSYIEHIFE
CCCCCCCHHHHHHHH
30.2522617229
62PhosphorylationLDKDNLSYIEHIFEI
CCCCCCHHHHHHHHH
17.3123403867
78SulfoxidationRRPDLLTMVVDYRTR
CCCCHHHHHHCCCCE
2.5230846556
90PhosphorylationRTRVLKISEEDELDT
CCEEEECCCHHHHCH
33.0925849741
97PhosphorylationSEEDELDTKLTRIPS
CCHHHHCHHHCCCCC
40.3526261332
98UbiquitinationEEDELDTKLTRIPSA
CHHHHCHHHCCCCCH
47.7521906983
982-HydroxyisobutyrylationEEDELDTKLTRIPSA
CHHHHCHHHCCCCCH
47.75-
100PhosphorylationDELDTKLTRIPSAKK
HHHCHHHCCCCCHHH
28.2723403867
104PhosphorylationTKLTRIPSAKKYKDI
HHHCCCCCHHHHHHH
50.8026846344
108PhosphorylationRIPSAKKYKDIIRQP
CCCCHHHHHHHCCCC
17.1223927012
109MethylationIPSAKKYKDIIRQPS
CCCHHHHHHHCCCCC
51.86116252721
116PhosphorylationKDIIRQPSEEEIIKL
HHHCCCCCHHHHHHH
49.6729255136
119UbiquitinationIRQPSEEEIIKLAPP
CCCCCHHHHHHHCCC
46.06-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
104SPhosphorylationKinasePKC-FAMILY-GPS
104SPhosphorylationKinasePKC_GROUP-PhosphoELM
116SPhosphorylationKinaseAKT1P31749
PSP
116SPhosphorylationKinaseAKT-FAMILY-GPS
116SPhosphorylationKinaseCAMK2-FAMILY-GPS
116SPhosphorylationKinaseCAM-KII_GROUP-PhosphoELM
116SPhosphorylationKinasePKB_GROUP-PhosphoELM

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of PEA15_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of PEA15_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
KS6A3_HUMANRPS6KA3physical
12796492
PLD1_HUMANPLD1physical
10926929
CASP8_HUMANCASP8physical
10493725
FADD_HUMANFADDphysical
10493725
MK03_HUMANMAPK3physical
11702783
MK01_HUMANMAPK1physical
11702783

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of PEA15_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach.";
Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.;
Anal. Chem. 81:4493-4501(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-116, AND MASSSPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-116, AND MASSSPECTROMETRY.
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column.";
Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.;
Anal. Sci. 24:161-166(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-116, AND MASSSPECTROMETRY.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-6; SER-25; SER-104;TYR-108 AND SER-116, AND MASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-104 AND SER-116, ANDMASS SPECTROMETRY.

TOP